Catalyst Wire Dossier Catalyst Wire Dossier

Aromatase inhibitors (class)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aromatase inhibitors (class), covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients

See pricing